Striking the Balance: Optimising Hepatitis B Tr...

By Thanusha Pillay

June 21, 2024

Introduction Hepatitis B virus (HBV) infection poses a significant global health challenge, with 296 million people affected worldwide in 2019. The World Health Organization (WHO)
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Enhancing Surgical Recovery Predictions with AI: A New Approach
The Economic Benefits of Preventive Health Programs
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Brucellosis Control in Armenia: A Holistic Approach
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Enhancing Clinician Accuracy in EEG Pattern Classification with AI
Advancing Pneumococcal Disease Prevention in Japan with PCV20